Jubilant Biosys announce strategic joint venture with Pierre Fabre to acquire its R&D centre in France, to enter into Biologics (mABs) and ADCs
Jubilant Biosys Limited to add Drug Discovery & Preclinical Development capabilities in Biologics and Antibody Drug Conjugate
